Moreover, the IHC results indicated that Ki-67 expression was low in the sh-HSPA5 groups, which demonstrated that downregulation of HSPA5 inhibited tumour growth in vivo (Figure 9C). The gene discussed is HSPA5; the disease is neoplasm.